• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by OTR Acquisition Corp.

    2/18/22 4:37:06 PM ET
    $OTRA
    Get the next $OTRA alert in real time by email
    SC 13G 1 tm227224d1_sc13g.htm SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ____)*

     

    OTR Acquisition Corp.

    (Name of Issuer)

     

    Class A Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

     

    67113Q105

    (CUSIP Number)

     

    February 15, 2022

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)

     

    x Rule 13d-1(c)

     

    ¨ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    Page 1 of 12 Pages

     

     

    CUSIP No. 67113Q105

     

    1.Names of Reporting Persons

     

    Arena Investors, LP

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)        ¨
    (b)        x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

     Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 536,880
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 536,880
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

     536,880

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
     ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

     5.1%

     

    12.Type of Reporting Person (See Instructions)

     

     PN

     

    Page 2 of 12 Pages

     

     

    CUSIP No. 67113Q105

     

    1.Names of Reporting Persons

     

    Arena Investors GP, LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)        ¨
    (b)        x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

     Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 536,880
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 536,880
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

     536,880

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
     ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

     5.1%

     

    12.Type of Reporting Person (See Instructions)

     

     OO

     

    Page 3 of 12 Pages

     

     

    CUSIP No. 67113Q105

     

    1.Names of Reporting Persons

     

    Arena Finance Markets, LP

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)        ¨
    (b)        x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

     Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 372,159
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 372,159
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

     372,159

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
     ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

     3.5%

     

    12.Type of Reporting Person (See Instructions)

     

     PN

     

    Page 4 of 12 Pages

     

     

    CUSIP No. 67113Q105

     

    1.Names of Reporting Persons

     

    Arena Finance Markets GP, LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)        ¨
    (b)        x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

     Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 372,159
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 372,159
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

     372,159

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
     ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

     3.5%

     

    12.Type of Reporting Person (See Instructions)

     

     OO

     

    Page 5 of 12 Pages

     

     

    CUSIP No. 67113Q105

     

    1.Names of Reporting Persons

     

    Arena Special Opportunities (Offshore) Master, LP

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)        ¨
    (b)        x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

     Cayman Islands

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 164,721
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 164,721
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

     164,721

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
     ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

     1.5%

     

    12.Type of Reporting Person (See Instructions)

     

     PN

     

    Page 6 of 12 Pages

     

     

    CUSIP No. 67113Q105

     

    1.Names of Reporting Persons

     

    Arena Special Opportunities Fund (Offshore) II GP, LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)        ¨
    (b)        x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

     Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 164,721
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 164,721
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

     164,721

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
     ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

     1.5%

     

    12.Type of Reporting Person (See Instructions)

     

     PN

     

    Page 7 of 12 Pages

     

     

    Item 1.

     

    (a)The name of the issuer is OTR Acquisition Corp. (the “Issuer”).

     

    (b)The principal executive offices of the Issuer are located at 1395 Brickell Avenue, Suite 800, Miami, FL 33131.

     

    Item 2.

     

    (a)This Schedule 13G is filed by the following (the “Reporting Persons”):

     

    (i)Arena Investors, LP (the “Investment Manager”), who serves as investment manager to the Arena Funds (defined below);

     

    (ii)Arena Investors GP, LLC, who serves as the general partner of the Investment Manager (the “IM General Partner”);

     

    (iii)Arena Finance Markets, LP (“AFM”);

     

    (iv)Arena Finance Markets GP, LLC, who serves as the general partner of AFM (the “AFM General Partner”);

     

    (v)Arena Special Opportunities (Offshore) Master, LP (“ASOFM”, and together with AFM, the “Arena Funds”); and

     

    (vi)Arena Special Opportunities Fund (Offshore) II GP, LLC, who serves as the general partner of ASOFM (the “ASOFM General Partner”).

     

    The Arena Funds are private investment vehicles. The Arena Funds directly own the Common Stock (as defined below) reported in this Schedule 13G.

     

    The Investment Manager may be deemed to indirectly beneficially own the Common Stock owned by the Arena Funds.

     

    The IM General Partner may be deemed to beneficially own the Common Stock beneficially owned by the Investment Manager.

     

    The AFM General Partner may be deemed to indirectly beneficially own the Common Stock owned by AFM.

     

    The ASOFM General Partner may be deemed to indirectly beneficially own the Common Stock owned by ASOFM.

     

    Each Reporting Person disclaims beneficial ownership with respect to any Common Stock other than the Common Stock directly owned by such Reporting Person.

     

    Page 8 of 12 Pages

     

     

    (b)The principal business office of the Reporting Persons is 405 Lexington Avenue, 59th Floor, New York, New York 10174.

     

    (c)For citizenship information see Item 4 of the cover page of each Reporting Person.

     

    (d)This Statement relates to the Class A Common Stock, $0.0001 par value per share, of the Issuer (the “Common Stock”).

     

    (e)The CUSIP Number of the Common Stock is 67113Q105.

     

    Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)¨Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b)¨Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c)¨Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d)¨Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e)¨An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)¨An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)¨A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)¨A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)¨A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)¨A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
    (k)¨Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________

     

    Item 4. Ownership.

     

    See Items 5-9 and 11 on the cover page for each Reporting Person, and Item 2, which information is given as of the close of business on the Event Date of February 15, 2022 and remains accurate as of the close of businesses on February 17, 2022, the business day before the date of this filing.

     

    The percentage ownership of each Reporting Person is based on 10,630,179 shares of Common Stock outstanding as of September 30, 2021, as reported by the Issuer in its Form 10-Q/A, filed with the Securities and Exchange Commission on December 13, 2021.

     

    Page 9 of 12 Pages

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ¨

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10. Certification.

     

    (a)Not applicable.

     

    (b)Not applicable.

     

    (c)By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

     

    Page 10 of 12 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 18, 2022

     

    Arena Investors, LP

    Arena Investors GP, LLC

    Arena Finance Markets, LP

    Arena Finance Markets GP, LLC

    Arena Special Opportunities (Offshore) Master, LP

    Arena Special Opportunities Fund (Offshore) II GP, LLC

     

    By: /s/ Lawrence Cutler  

    Name: Lawrence Cutler

    Title: Authorized Signatory

     

    Page 11 of 12 Pages

     

     

    EXHIBIT INDEX

     

    Exhibit No.   Document
         
    1   Joint Filing Agreement

     

    Page 12 of 12 Pages

     

    Get the next $OTRA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OTRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OTRA
    SEC Filings

    View All

    SEC Form 15-12B filed by OTR Acquisition Corp.

    15-12B - OTR Acquisition Corp. (0001821318) (Filer)

    5/31/22 8:00:30 AM ET
    $OTRA

    OTR Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OTR Acquisition Corp. (0001821318) (Filer)

    5/24/22 4:31:11 PM ET
    $OTRA

    SEC Form 25-NSE filed by OTR Acquisition Corp.

    25-NSE - OTR Acquisition Corp. (0001821318) (Subject)

    5/19/22 4:06:33 PM ET
    $OTRA

    $OTRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics

    – Business combination transaction with OTR Acquisition Corp., a special purpose acquisition company, completed – – Combined company Comera Life Sciences Holdings, Inc. will be listed on the Nasdaq Capital Market under ticker symbol "CMRA" – Comera Life Sciences Holdings, Inc. ("Comera" or the "Company"), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced the completion of its business combination with OTR Acquisition Corp. (NASDAQ:OTRAU, OTRA and OTRAW))) (referred herein as "OTR"), a publicly traded special purpose acquisition company (SPAC). Comera Life Sciences Holdings, Inc., the resulting comb

    5/20/22 8:00:00 AM ET
    $OTRA
    $OTRAU
    Business Services
    Finance

    Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation

    Comera Life Sciences, Inc. ("Comera" or the "Company"), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it has entered into a research collaboration with a top 10 global pharmaceutical company and developer of medicines across oncology, hematology and immunology and other therapeutic areas. Under the terms of the agreement, Comera will utilize its proprietary SQore™ formulation platform to develop a subcutaneous formulation of the partner's currently marketed medicine. "Our second announced collaboration this year is a critical milestone in our long-term strategy to partner with top-tier pharma c

    5/9/22 8:00:00 AM ET
    $OTRA

    Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo

    Comera Life Sciences, Inc., which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that Robert P. Mahoney, Ph.D., Chief Scientific Officer, will present at the PEGS Boston Conference & Expo, being held May 2-6, 2022, in-person. Dr. Mahoney will discuss Comera's lead, patented caffeine-based excipient, which significantly reduced the viscosity of prominent monoclonal antibodies without affecting their stability or biologic activity in a recent peer-reviewed study.1 The presentation details are as follows: Title: Viscosity Reducing Excipients for Highly Concentrated Antibody Formulations Time: May 4, 202

    4/27/22 8:00:00 AM ET
    $OTRA

    $OTRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Gray Glenn Evan converted options into 22,123 shares and disposed of 100,000 shares

    4 - OTR Acquisition Corp. (0001821318) (Issuer)

    5/20/22 4:37:26 PM ET
    $OTRA

    SEC Form 4: Otr Acquisition Sponsor Llc converted options into 1,305,918 shares and disposed of 1,305,918 shares

    4 - OTR Acquisition Corp. (0001821318) (Issuer)

    5/20/22 4:35:50 PM ET
    $OTRA

    SEC Form 4: Besner Nadav converted options into 5,000 shares and disposed of 5,000 shares

    4 - OTR Acquisition Corp. (0001821318) (Issuer)

    5/20/22 4:36:27 PM ET
    $OTRA

    $OTRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by OTR Acquisition Corp. (Amendment)

    SC 13G/A - OTR Acquisition Corp. (0001821318) (Subject)

    1/24/23 9:57:09 AM ET
    $OTRA

    SEC Form SC 13G/A filed by OTR Acquisition Corp. (Amendment)

    SC 13G/A - OTR Acquisition Corp. (0001821318) (Subject)

    5/20/22 4:37:55 PM ET
    $OTRA

    SEC Form SC 13G/A filed by OTR Acquisition Corp. (Amendment)

    SC 13G/A - OTR Acquisition Corp. (0001821318) (Subject)

    5/10/22 4:19:44 PM ET
    $OTRA